Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Open-market sale Director sold 188,322 shares at $0.55 ($103,050)
  2. 4 Open-market sale Director sold 5,436,673 shares at an average $0.55 ($3,009,262)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Other disposition Director disposed of 4,120,854 shares (other)
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Director acquired 6,818 shares (grant or award)
  12. 4 Grant or award Director acquired 6,817 shares (grant or award)
  13. 4 Grant or award Director acquired 7,953 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Director acquired 49,998 shares (grant or award)
  16. 4 Grant or award Director acquired 31,817 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 150,000 shares (grant or award)
  18. 4 Open-market buy Director bought 6,857,143 shares at $1.75 ($12,000,000)
  19. 4 Open-market buy Director bought 350,000 shares at $1.75 ($612,500)
  20. 4 Open-market buy Director bought 50,000 shares at $1.75 ($87,500)

Page 16 of 29 · 564 filings